Corn oil intake favorably impacts lipoprotein cholesterol, apolipoprotein and lipoprotein particle levels compared with extra-virgin olive oil

European Journal of Clinical Nutrition

Volumn 71, Issue 1, 2017, Pages 33-38

  Maki, K C ^a,b   Lawless, A L ^b   Kelley, K M ^b   Kaden, V N ^b   Geiger, C J ^c   Palacios, O M ^a   Dicklin, M R ^a,b  

^a MB Clinical Research   (United States)

^b Biofortis Innovation Services Merieux NutriSciences   (United States)

^c Geiger and Associ LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; CORN OIL; EXTRA VIRGIN OLIVE OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; APOA1 PROTEIN, HUMAN; LIPOPROTEIN CHOLESTEROL; OLIVE OIL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FOOD INTAKE; HUMAN; MALE; BLOOD; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EATING; MIDDLE AGED; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

APOLIPOPROTEIN A-I; APOLIPOPROTEINS; APOLIPOPROTEINS B; CHOLESTEROL; CORN OIL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EATING; FEMALE; HUMANS; LIPOPROTEINS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OLIVE OIL;

EID: 84988932827     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2016.169     Document Type: Article

References (45)

1. Heart Disease Facts and Statistics. Centers for Disease Control and Prevention, 2015. Available at http://www.cdc.gov/heartdisease/facts.htm (accessed on 19 February 2016)
2. Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE, Jones PH et al. National lipid association recommendations for patient-centered management of dyslipidemia: part 1-full report. J Clin Lipidol 2015; 9: 129-169
3. Jacobson TA, Maki KC, Orringer CE, Jones PH, Kris-Etherton P, Sikand G et al. National lipid association recommendations for patient-centered management of dyslipidemia: part 2. J Clin Lipidol 2015; 9: S1-S122.e1
4. Expert Dyslipidemia Panel of the International Atherosclerosis Society Panel members. An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia-full report. J Clin Lipidol 2014; 8: 29-60
5. Eckel RH, Jakicic JM, Ard JD, de Jesus JM, Houston Miller N, Hubbard VS et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: 2960-2984
6. Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011; 32: 1769-1818
7. Department of Health and Human Services and US Department of Agriculture. 2015-2020 Dietary Guidelines for Americans. 8th edn, 2015. Available at: http:// health.gov/dietaryguidelines/2015/guidelines
8. Maki KC, Lawless AL, Kelley KM, Kaden VN, Geiger CJ, Dicklin MR. Corn oil improves the plasma lipoprotein lipid profile compared with extra-virgin olive oil consumption in men and women with elevated cholesterol: results from a randomized controlled feeding trial. J Clin Lipidol 2015; 9: 49-57
9. Berry EM, Eisenberg S, Haratz D, Friedlander Y, Norman Y, Kaufmann NA et al. Effects of diets rich in monounsaturated fatty acids on plasma lipoproteins-The Jerusalem Nutrition Study: high MUFAs vs high PUFAs. Am J Clin Nutr 1991; 53: 899-907
10. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb 1992; 12: 911-919
11. Kulkarni KR, Garber DW, Schmidt CF, Marcovina SM, Ho MH, Wilhite BJ et al. Analysis of cholesterol in all lipoprotein classes by single vertical ultracentrifugation of fingerstick blood and controlled-dispersion flow analysis. Clin Chem 1992; 38: 9
12. Kulkarni KR, Garber DW, Marcovina SM, Segrest JP. Quantification of cholesterol in all lipoprotein classes by the VAP-II method. J Lipid Res 1994; 35: 159-168
13. Maki KC, Dicklin MR, Davidson MH, Mize PD, Kulkarni KR. Indicators of the atherogenic lipoprotein phenotype measured with density gradient ultracentrifugation predict changes in carotid intima-media thickness in men and women. Vasc Health Risk Manag 2012; 8: 31-38
14. Kulkarni KR, French KW. Determination of Apolipoprotein B100 by the Vertical Auto Profile Method, Birmingham, AL. Clin Chem 2007; 53
15. Kulkarni KR, Stewart T, Maddox E. Low density lipoprotein particle concentration measurement by the Verticle Lipoprotein Profile (VLP) Method, Birmingham, AL. Natl Lipid Assoc 2014; 8: 298-299
16. Kulkarni K, Tiwari H, Moore L, Jones S. A novel approach to measure apolipoprotein B/apolipoprotein AI ratio using the Vertical Auto Profile method. Diab Vasc Dis Res 2007; 4: 266
17. Mifflin MD, Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO. A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr 1990; 51: 241-247
18. Sallis JF, Haskell WL, Wood PD, Fortmann SP, Rogers T, Blair SN et al. Physical activity assessment methodology in the Five-City Project. Am J Epidemiol 1985; 121: 91-106
19. Wagner KH, Tomasch R, Elmadfa I. Impact of diets containing corn oil or olive/sunflower oil mixture on the human plasma and lipoprotein lipid metabolism. Eur J Nutr 2001; 40: 161-167
20. Clarke R, Frost C, Collins R, Appleby P, Peto R. Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ 1997; 314: 112-117
21. Heyden S. Polyunsaturated and monounsaturated fatty acids in the diet to prevent coronary heart disease via cholesterol reduction. Ann Nutr Metab 1994; 38: 117-122
22. Lichtenstein AH, Ausman LM, Carrasco W, Jenner JL, Gualtieri LJ, Goldin BR et al. Effects of canola, corn, and olive oils on fasting and postprandial plasma lipoproteins in humans as part of a National Cholesterol Education Program Step 2 diet. Arterioscler Thromb 1993; 13: 1533-1542
23. Racette SB, Lin X, Lefevre M, Spearie CA, Most MM, Ma L et al. Dose effects of dietary phytosterols on cholesterol metabolism: a controlled feeding study. Am J Clin Nutr 2010; 91: 32-38
24. US Department of Agriculture Nutrition Evidence Library: What is the effect of dietary PUFA intake on health and intermediate health outcomes? Available at: http://www.nel.gov/evidence.cfm?evidence-summary-id=250137 (accessed on 25 March 2016)
25. Ramsden CE, Zamora D, Majchrzak-Hong S, Faurot KR, Broste SK, Frantz RP et al. Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73). BMJ 2016; 353: i1246
26. Research Review: Old data on dietary fats in context with current recommendationzs. Ask the Expert: Harvard School of Public Health, 2016. Available at: https://www.hsph.harvard.edu/nutritionsource/2016/04/13/diet-heart-ramsdenmce-bmj-comments/ (accessed on 17 June 2016)
27. Maki KC, Bays HE, Dicklin MR, Johnson SL, Shabbout M. Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia. J Clin Lipidol 2011; 5: 483-492
28. Bays H, Conard S, Leiter LA, Bird S, Jensen E, Hanson ME et al. Are post-treatment low-density lipoprotein subclass pattern analyses potentially misleading? Lipids Health Dis 2010; 9: 136
29. Choi CU, Seo HS, Lee EM, Shin SY, Choi UJ, Na JO et al. Statins do not decrease small, dense low-density lipoprotein. Tex Heart Inst J 2010; 37: 421-428
30. Berryman CE, West SG, Fleming JA, Bordi PL, Kris-Etherton PM. Effects of daily almond consumption on cardiometabolic risk and abdominal adiposity in healthy adults with elevated LDL-cholesterol: a randomized controlled trial. J Am Heart Assoc 2015; 4: e000993
31. Wang L, Bordi PL, Fleming JA, Hill AM, Kris-Etherton PM. Effect of a moderate fat diet with and without avocados on lipoprotein particle number, size and subclasses in overweight and obese adults: a randomized, controlled trial. J Am Heart Assoc 2015; 4: e001355
32. Nigon F, Lesnik P, Rouis M, Chapman MJ. Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. J Lipid Res 1991; 32: 1741-1753
33. Folse HJ, Goswami D, Rengarajan B, Budoff M, Kahn R. Clinical-and costeffectiveness of LDL particle-guided statin therapy: a simulation study. Atherosclerosis 2014; 236: 154-161
34. Cole TG, Contois JH, Csako G, McConnell JP, Remaley AT, Devaraj S et al. Association of apolipoprotein B and nuclear magnetic resonance spectroscopyderived LDL particle number with outcomes in 25 clinical studies: assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices. Clin Chem 2013; 59: 752-770
35. Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen MR, Wiklund O et al. ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis 2011; 217: 3-46
36. Davidson MH, Ballantyne CM, Jacobson TA, Bittner VA, Braun LT, Brown AS et al. Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists. J Clin Lipidol 2011; 5: 338-367
37. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA et al. American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement-executive summary. Endocr Pract 2013; 19: 536-557
38. Dunbar RL, Nicholls SJ, Maki KC, Roth EM, Orloff DG, Curcio D et al. Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial. Lipids Health Dis 2015; 14: 98
39. Fisher EA, Feig JE, Hewing B, Hazen SL, Smith JD. High-density lipoprotein function, dysfunction, and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 2012; 32: 2813-2820
40. Sorci-Thomas MG, Thomas MJ. Why targeting HDL should work as a therapeutic tool, but has not. J Cardiovasc Pharmacol 2013; 62: 239-246
41. Guidance for Industry: Evidence-Based Review System for the Scientific Evaluation of Health Claims-Final. US Food and Drug Administration, 2009; updated 07/01/ 2016. Available at: http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocu mentsRegulatoryInformation/LabelingNutrition/ucm073332.htm (accessed on 26 August 2016)
42. Appel LJ, Sacks FM, Carey VJ, Obarzanek E, Swain JF, Miller ER et al. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA 2005; 294: 2455-2464
43. Hooper L, Martin N, Abdelhamid A, Davey Smith G. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev 2015; 6: CD011737
44. Li Y, Hruby A, Bernstein AM, Ley SH, Wang DD, Chiuve SE et al. Saturated fats compared with unsaturated fats and sources of carbohydrates in relation to risk of coronary heart disease: a prospective cohort study. J Am Coll Cardiol 2015; 66: 1538-1548
45. Wang Q, Afshin A, Yakoob MY, Singh GM, Rehm CD, Khatibzadeh S et al. Impact of nonoptimal intakes of saturated, polyunsaturated, and trans fat on global burdens of coronary heart disease. J Am Heart Assoc; e-pub ahead of print 20 January 2016; doi:10.1182/blood-2013-11-539098